Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL475592 | 0.98 | CHRM2 (0.35) | CHRM2CYP2D6CHRM1ADRA2CCHRM3 | |
| Hydrochloric Acid SCHEMBL6117337 | 0.93 | DNM1 (0.36) | CHRM2CYP2D6CHRM1ADRA2CCHRM3 | |
| Bromide SCHEMBL23607564 | 0.91 | DNM1 (0.42) | DNM1KDM4EMAPK1HIF1AMEN1 | |
| SCHEMBL9820844 | 0.91 | TGFBR1 (0.33) | CHRM2CYP2D6CHRM1ADRA2CCHRM3 | |
| SCHEMBL7056776 | 0.89 | CHRM2 (0.44) | CHRM2CYP2D6CHRM1ADRA2CCHRM3 | |
| Bromide SCHEMBL6116969 | 0.87 | CHRM2 (0.43) | CHRM2CYP2D6CHRM1ADRA2CCHRM3 | |
| Hydrochloric Acid SCHEMBL475743 | 0.87 | CHRM2 (0.43) | CHRM2CYP2D6CHRM1ADRA2CCHRM3 | |
| SCHEMBL6117441 | 0.87 | TGFBR1 (0.30) | TGFBR1 | |
| SCHEMBL15253793 | 0.86 | EPHX1 (0.46) | HIF1AEPHX1PLA2G2AALDH1A1PLA2G4A | |
| SCHEMBL9351903 | 0.84 | KDM4E (0.33) | KDM4EMAPK1HIF1ATGFBR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8413719-B2 | Relative permeability modification | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2013-04-09 | — | — | US | claimed |
| US-20100230106-A1 | Relative Permeability Modification | SCHLUMBERGER TECHNOLOGY CORPORATION | 2010-09-16 | — | — | US | claimed |
| WO-2010103421-A1 | RELATIVE PERMEABILITY MODIFICATION | SCHLUMBERGER CANADA LIMITED (CA) | 2010-09-16 | — | — | WO | claimed |
| EP-1490016-B1 | CATIONIC POLYMERS AND THE USE THEREOF IN COSMETIC FORMULATIONS | BASF AG (DE) | 2007-06-06 | — | — | EP | claimed |
| EP-1188571-B1 | Ink-jet printing method | MEADWESTVACO CORP (US) | 2005-05-11 | — | — | EP | claimed |
| US-20050084469-A1 | Cationic polymers and the use thereof in cosmetic formulations | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-21 | — | — | US | claimed |
| EP-1490016-A1 | CATIONIC POLYMERS AND THE USE THEREOF IN COSMETIC FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-29 | — | — | EP | claimed |
| WO-2003106522-A1 | POLYOXYALKYLENE-SUBSTITUTED ALKYLENE DIAMINES AND THE USE THEREOF IN COSMETIC FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2003-12-24 | — | — | WO | claimed |
| WO-2003080001-A1 | CATIONIC POLYMERS AND THE USE THEREOF IN COSMETIC FORMULATIONS | BASF AKTIENGESELLSCHAFT (DE) | 2003-10-02 | — | — | WO | claimed |
| EP-0225192-B1 | PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF MANUFACTURING COLOR FILTER USING THE SAME | KABUSHIKI KAISHA TOSHIBA (JP) | 1991-10-09 | — | — | EP | claimed |
| EP-4399274-A1 | METHOD OF HARVESTING BIOLOGICS | Solventum Intellectual Properties Company (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20240131450-A1 | CHARGED DEPTH FILTER FOR THERAPEUTIC BIOTECHNOLOGY MANUFACTURING PROCESS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-04-25 | — | — | US | disclosed |
| EP-4297884-A1 | CHARGED DEPTH FILTER FOR THERAPEUTIC BIOTECHNOLOGY MANUFACTURING PROCESS | 3M Innovative Properties Company (US) | 2024-01-03 | — | — | EP | disclosed |
| US-11692123-B2 | Method of consolidating subterranean formations using cationic and anionic and/or non-ionic polymers | PETROLIAM NASIONAL BERHAD (PETRONAS) (MY) | 2023-07-04 | — | — | US | disclosed |
| WO-2023084075-A1 | METHOD FOR INCREASING THE EFFICACY OF A HERBICIDE | BASF SE (DE) | 2023-05-19 | — | — | WO | disclosed |
| EP-0988152-A1 | COATING COMPOSITION AND PRINTING MEDIUM | PPG Industries Ohio, Inc. (US) | 2000-03-29 | — | — | EP | disclosed |
| EP-0988154-A1 | COATING COMPOSITION AND PRINTING MEDIUM | PPG Industries Ohio, Inc. (US) | 2000-03-29 | — | — | EP | disclosed |
| US-5880196-A | VOLATILE AQUEOUS LIQUID MEDIUM CONTAINING ONIUM-FREE AND ONIUM-CONTAINING POLYMERIC BINDERS, FINELY DIVIDED PSEUDOBOEHMITE PARTICLES; NONBLEEDING | PPG INDUSTRIES, INC. (US) | 1999-03-09 | — | — | US | disclosed |
| WO-1998056591-A1 | COATING COMPOSITION AND PRINTING MEDIUM | PPG INDUSTRIES OHIO, INC. (US) | 1998-12-17 | — | — | WO | disclosed |
| WO-1998056592-A1 | COATING COMPOSITION AND PRINTING MEDIUM | PPG INDUSTRIES OHIO, INC. (US) | 1998-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050084469-A1 | Cationic polymers and the use thereof in cosmetic formulations | PARN, CUTA, PARG | CHRM2 3747/4885CYP2D6 4516/4885CHRM1 3924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.